請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/48284完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 潘子明 | |
| dc.contributor.author | Ya-Wen Hsu | en |
| dc.contributor.author | 許雅雯 | zh_TW |
| dc.date.accessioned | 2021-06-15T06:51:15Z | - |
| dc.date.available | 2012-02-23 | |
| dc.date.copyright | 2011-02-23 | |
| dc.date.issued | 2011 | |
| dc.date.submitted | 2011-02-15 | |
| dc.identifier.citation | 玉田英明。1988。紅麴各種調味料之應用。食品及科學。July:96-99。
林讚峰。1994。紅麴菌的特性及應用。生物產業。5:29-35。 林讚峰。1995。紅麴菌培養工藝及紅麴應用之演進。製酒科技專論彙編。17:156-168。 許紅峰、毛寧、黃諺諺與馬宏。1999。紅曲黴菌絲體及發酵濾液抗疲勞作用之研究。中國體育科技。35:50-52。 許贛榮與傅金泉。1998。紅麴產品的合法化與菌種分離及有害物質橘黴素-當今歐紅麴生產及應用的焦點。中國釀造。5:6-10。 陳明造、林坤炳、郭秀蘭與曹穎玉。1997。豬肉在紅麴菌、乳酸菌和酵母菌等培養液浸漬期間色澤、TBA及VBN的變化。中華農學會報。181:68-75。 陳彥霖。1999。紅麴與高血壓。科學與技術。32:1-2。 陳彥霖、李昭蓉、陳建州與袁國芳。1998。紅麴菌種的研究開發與應用。食品工業。30:1-10。 陳倩琪。2009。紅麴。食品工業。41:22-39。 陳慶源、莊淑惠。2003。綜論紅麴產品之開發與應用。食品工業。35:1-2。 國家中醫藥管理局中華本草編委會。1999。中華本草。上海科學技術出版社。1:488-489。 黃之丞。2010。紅麴山藥酒精萃取物緩解放射線治療衍生之副作用。國立臺灣大學微生物與生化學研究所碩士論文。台北。台灣。中華民國。 蘇遠志、陳文亮、方鴻源、方浩慶與王文祥。1970。紅麴菌(Monascus anka)之菌學研究。中國農業化學會誌。8:45-58。 蘇遠志與黃冬梨。1981。紅麴色素之動物飼養試驗。國立台灣大學農學院研究報告。21:98-112。 Ahmad, N., Srivastava, R.C. Agarwal, R. and Mukhtar, H. 1997. Nitric oxide synthase and skin tumor promotion. Biochem Biophys Res Commun. 232:328-331. Akihisa, T., Tokuda, H., Yasukawa, K., Ukiya, M., Kiyota, A., Sakamoto, N., Suzuki, T., Tanabe, N., and Nishino, H. 2005. Azaphilones, furanoisophthalides, and amino acids from the extracts of Monascus pilosus-fermented rice (red-mold rice) and their chemopreventive effects. J Agric Food Chem. 53:562-565. Alberts, A.W., Chen, J., Kuron, G., Hunt, V., Huff, J., Hoffman, C., Rothrock, J., Lopez, M., Joshua, H., Harris, E., Patchett, A., Monaghan, R., Currie, S., Stapley, E., Albers-Schonberg, G., Hensens, O., Hirshfield, J., Hoogsteen, K., Liesch, J., and Springer, J. 1980. Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent. Proc Natl Acad Sci U S A. 77:3957-3961. Aniya, Y., Yokomakura, T., Yonamine, M., Shimada, K., Nagamine, T., Shimabukuro, M., and Gibo, H. 1999. Screening of antioxidant action of various molds and protection of Monascus anka against experimentally induced liver injuries of rats. Gen Pharmacol. 32:225-231. Aniya, Y., Ohtani, II, Higa, T., Miyagi, C., Gibo, H., Shimabukuro, M., Nakanishi, H., and Taira, J. 2000. Dimerumic acid as an antioxidant of the mold, Monascus anka. Free Radic Biol Med. 28:999-1004. Blanc, P.J., Laussac, J.P., Le Bars, J., Le Bars, P., Loret, M.O., Pareilleux, A., Prome, D., Prome, J.C., Santerre, A.L., and Goma, G. 1995. Characterization of monascidin A from Monascus as citrinin. Int J Food Microbiol. 27:201-213. Budavari, S., Maryadele, J.O., Smith, A., and Heckelman, P.E. 1989. The Merck Index. 11:2330-2331. Chen, W.P., HO, B.Y., L, C.L., Lee, C.H., and Pan, T.M. 2008. Red mold rice prevents the development of obesity, dyslipidemia and hyperinsulinemia induced by high-fat diet. Int J Obes. 32:1694-1704. Cheng, M.J., Wu, M.D., Chen, I.S., and Yuan, G.F. 2008. Secondary metabolites from the mycelia of the fungus Monascus pilosus BCRC 38072. Chem Pharm Bull. 56:394-397. Cheng, M.J., Wu, M.D., Yang, P.S., Chen, J.J., Chen, I.S., Chen, Y.L., and Yuan, G.F. 2010a. Secondary metabolites isolated from the fungus Monascus kaoviang-fermented rice. J Chin Chem Soc. 55:107-110. Cheng, M.J., Chen, J.J., Wu, M.D., Yang, P.S., and Yuan, G.F. 2010b. Isolation and structure determination of one new metabolite isolated from the red of Monascus purpureus. Nat Prod Res. 24:979-988. Cheng, M.J., Wu, M.D., Chen, I.S., and Yuan, G.F. 2010c. A new sesquiterpene isolated from the extracts of fungus Monascus pilosus-fermented rice. Nat Prod Res. 24:750-758. Chin, K., Kurashima, Y., Ogura, T., Tajiri, H., Yoshida, S., and Esumi, H. 1997. Induction of vascular endothelial growth factor by nitric oxide in human glioblastoma and hepatocellular carcinoma cells. Oncogene. 15:437-442. Endo, A. 1979. Monacolin K, a new hypocholesterolemic agent produced by a Monascus species. J Antibiot (Tokyo). 32:852-854. Endo, A., Hasumi, K., and Negishi, S. 1985. Monacolins J and L, new inhibitors of cholesterol biosynthesis produced by Monascus ruber. J Antibiot (Tokyo). 38:420-422. Frederick, C.B., Bentley, M.D., and Shive, W. 1981. Structure of triornicin, a new siderophore. Biochemistry 20:2436-2438. Hadfield, J.R., Holker, J.S.E., and Stanway, D.N. 1967. The biosynthesis of fungal metabolites. Part II. The -oxo-lactone equivalents in rubropunctatin and monascorubrin. J Chem Soc C-Org. 8:751-755. Haws, E.J., Holker, J.S.E., Kelly A., Powell, A.D.G., and Roberston, A. 1959. 722. The chemistry of fungi. Part XXXVII. The structure of rubropunctatin. J Chem. Soc. 3598-3586. Ho, B. Y., and Pan, T. M. 2009. The Monascus metabolite, monacolin K, reduces tumor progression and metastasis of Lewis lung carcinoma cells. J Agri Food Chem. 57: 8258-8265. Ho, B. Y., Wu, Y. M., Hsu, Y. W., Kuo, Y. H., Chang, K. J., Pan, T. M. 2011. Dimerumic acid inhibits SW620 human colorectal cancer invasion by attenuation of H2O2-mediated MMP-7 expression via the JNK/c-Jun and ERK/c-Fos activation in an AP-1-dependent manner. (in submission) Hong, M.Y., Seeram, N.P., Heber, D. 2008a. Chinese red yeast rice versus lovastatin effects on prostate cancer cells with and without androgen receptor overexpression. J Med Food. 11:657-666. Hong, M.Y., Seeram, N.P., Heber, D. 2008b. Anticancer effects of Chinese red yeast rice versus monacolin K alone on colon cancer cells. J Nutr Biochem. 19:448-458. Hossain, C.F., Okuyama, E., and Yamazaki, M. 1996. Anew series of coumarin derivatives having monamine oxidase inhibitory activity from Monascus anka. Chem Pharm Bull. 44:1535-1539. Huang, Z., Xu, Y., Li, L., and Li, Y. 2008. Two new Monascus metablites with strong blue fluorescence isolated from red yeast rice. J Agric Food Chem. 56:112-118. Juzlova, P., Martinkova, L., and Kren, V. 1996a. Secondary metabolites of the fungus Monascus: a review. J Ind Microbiol. 16:163-170. Juzlova, P., Rezanka, T., Martinkova, L., and Kren, V. 1996b. Long-chain fatty acids from Monascus purpureus. Phytochemistry. 43:151-153. Jongrungruangchok, S., Kittakoop, P., Yongsmith, B., Bavovada, R., Tanasupawat, S., Lartpornatulee, N., and Thebtaranonth, Y. 2004. Azaphilone pigments from a yellow mutant of the fungus Monascus kaoliang. Phytochem. 65:2569-2575. Jou, P.C., Ho, B.Y., Hsu, Y.W., and Pan, T.Z. 2010. The effect of Monascus secondary polyketid metabolites, monascin and ankaflavin, on adipogenesis and lipolysis activity in 3T3-L1. J. Agric. Food Chem. 58: 12703–12709. Klaunig, J.E., Xu Y., Isenberg, J.S., Bachowski,S., Kolaja, K.L. Jiang, J., Stevenson D.E., and Walborg E.F. Jr. 1998, The role of oxidative stress in chemical carcinogenesis. Environ Health Perspect. 106 (Suppl 1):289-295. Knecht, A., Cramer, B., Humpf, H.U. 2006, New Monascus metabolites: Structure elucidation and toxicological properies studied with immortalized human kidney epithelial cells. Mol. Nutr. Food Res. 50, 314–321. Kuo, Y.H., Huang, H.C., Kuo Yang, L.M., Hsu, Y.W., Lee, K.H., Chang, F.R., and Wu, Y.C. 2005. New dammarane-type saponins from the galls of Sapindus mukorossi, J Agric Food Chem. 53: 4722–4727. Lee, C.L., Tsai, T.Y., Wang, J.J., and Pan, T.M. 2006a. In vivo hypolipidemic effects and safety of low dosage Monascus powder in a hamster model of hyperlipidemia. Appl Microbiol Biotechnol. 70: 533-540. Lee, C.L., Wang, J.J., Kuo, S.F., and Pan, T.M. 2006b. Monascus fermentation of dioscorea for increasing the production of cholesterol-lowering agent─monacolin K and antiinflammation agent─monascin. Appl Microbiol Biotecnol. 72:1254-1262. Lee, C.L., Kuo, T.F., Wang, J.J., and Pan, T.M. 2007. Red mold rice ameliorates impairment of memory and learning ability in intracerebroventricular amyloid beta-infused rat via repressing amyloid beta accumulation. J Neurosci Rese. 85:3171-3182. Lee, C.L., Wang, J.J., and Pan, T.M. 2008. Red mold rice extract represses amyloid beta peptide-induced neurotoxicity via potent synergism of anti-inflammatory and anti-oxidative effect. Appl Microbiol Biotechnol. 79:829-841. Lee, C.L., Kuo, T.F., Wu, C.L., Wang, J.J, and Pan, T.M. 2010a. Red mold rice promotes neuroprotective sAPPalpha secretion instead of Alzheimer’s risk factors and amyloid beta expression in hyperlipidemic Ab40-infused rats. J Agri Food Chem. 58:2230-2238. Lee, C.L., Kung, Y. H., Wu, C.L., Hsu, Y.W., and Pan, T.M. 2010b. Monascin and ankaflavin act novel hypolipidemic and high density lipoprotein cholesterol-raising agents in red mold dioscorea. J Agri Food Chem. 58:9013-9019. Li, C.L., Zhu, Y., Wang, Y.Y., Zhu, J.S., Chang, J., and Kritchevsky, D. 1998. Monascus purpureus-fermented rice (red yeast rice): a natural food product that lowers blood cholesterol in animal models of hypercholesterolemia. Nutr Res. 18:71-81. Li, J.J., Shang, X.Y., Li, L.L., Liu, M.T., Zheng, J.Q., and Jin, Z.L. 2010. New cytotoxic azaphilones from Monascus purpureus-fermented rice (red yest ric). Molecules 15:1958-1966. Li, Y.G., Zhang, F., Wang, Z.T., and Hu, Z.B. 2004. Identification and chemical profiling of monacolins in red yeast rice using high-performance liquid chromatography with photodiode array detector and mass spectrometry. J Pharm Biomed Ana. 35:1101-1112. Loret, M.O., and Morel, S. 2010. Isolation and structural characterization of two new metabolites from Monascus. J Agri Food Chem. 58: 1800-1803. Manchand, P.S., and Whalley, W.B. 1973. Isolation and structure of ankaflavin: A new pigment from Monascus anka. Phytochem. 12:2531-2532. Martinková, L., Patáková-Juzlová, P., Kren, V., Kucerová, Z., Havlicek, V., Olsovsky, P., Hovorka, O., Rihová, B., Vesely, D., Veselá, D., Ulrichová, J., and Prikrylová, V. 1999. Biological activities of oligoketide pigments of Monascus purpureus. Food Addit Contam. 16: 15-24. Moncada, S., Palmer, R.M., and Higgs, E.A. 1991. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43:109-142. Mordan, L.J., Burnett, T.S., Zhang, L.X., Tom, J., and Cooney, R.V. 1993. Inhibitors of endogenous nitrogen oxide formation block the promotion of neoplastic transformation in C3H 10T1/2 fibroblasts. Carcinogenesis. 14:1555-1559. Nozaki, H., Date, S., Kondo, H., Takaoda, D., Tada, T., and Nakayama, M. 1991. Ankalactone, a new α,β-unsaturated γ-lactone from Monascus anka. Agric Biol Chem. 55:899-900. Osmanova, N., Schultzw, W., and Ayoub, N. 2010. Azaphilones: a class of fungal metabolite with diverse biological activities. Phytochem Rev. 9:315-342. Pan, M.H., Ghai, G. and Ho, C.T., 2008. Food bioactives, apoptosis, and cancer. Mol Nutr Food Res. 52: 43-52. Ramos, S. 2008. Cancer chemoprevention and chemotherapy: Dietary polyphenols and signalling pathways. Mol. Nutr. Food Res. 52: 507-526. Robertson, F.M., Long, BW., Tober, K.L. Ross, M.S., and Oberyszyn, T.M. 1996. Gene expression and cellular sources of inducible nitric oxide synthase during tumor promotion. Carcinogenesis. 17:2053-2059. Saleem, M., Alam ,A., Arifin, S., Shah, M.S., Ahmed, B., and Sultana, S. 2001. Lupeol, a triterpene, inhibits early responses of tumor promotion induced by benzoyl peroxide in murine skin. Pharmacol Res. 43:127-34. Shi, Y.C. and Pan, T.M. 2010a. Anti-diabetic effects of Monascus purpureus NTU 568 fermented products on streptozotocin-induced diabetic rats. J Agri Food Chem. 58:7634-7640. Shi, Y.C. and Pan, T.M. 2010b. Antioxidant and pancreas-protective effect of red mold fermented products on streptozotocin-induced diabetic rats. J Sci Food & Agri. 90:2519-2525. Shimada, K., Fujikawa, K., Yahara, K. and Nakamura, T. 1992. Antioxidative properties of xanthan on the antioxidation of soybean oil in cyclodextrin emulsion. J. Agric Food Chem. 40:945-948. Sporn, M.B. 1976. Approaches to prevention of epithelial cancer during the preneoplastic period. Cancer Res. 36:2699-2702. Su, N.W., Lin, Y.L., Lee, M.H., and Ho, Y.H. 2005. Ankaflavin from Monascus-fermented red rice exhibits selective cytotoxic effect and induces cell death on HepG2. J Agric Food Chem. 53:1949-1954 Taira, J., Miyagi, C., Aniya, Y. 2002. Dimerumic acid as an antioxidant from the mold, Monascus anka: the inhibition mechanisms against lipid peroxidation and hemeprotein-mediated oxidation. Biochem Pharmacol. 63:1019-1026. Tsai, R.L., Ho, B.Y., and Pan T.M. 2009. Red mold rice mitigates oral carcinogenesis in 7,12-dimethyl-1,2-benz[a]anthracene-induced oral carcinogenesis in hamster. Evid Based Complement Altern Med. Advance Access published on December 17. Velíšek, J., Davídek, J., and Cejpek, K. 2008. Biosynthesis of food constituents: natural pigments. Part 2─a reviews. Czech J Food Sci. 26: 73-98. Wang, J.J., Shieh, M.J., Kuo, S.L., Lee, C.L., and Pan, T.M. 2006. Effect of red mold rice on antifatigue and exercise-related changes in lipid peroxidation in endurance exercise. Appl Microbiol Biotechnol. 70:247-253. Wild, D., Toth, G., and Humpf, H.U. 2002. New Monascus metabolite isolated from red yeast rice (angkak, red koji). J Agric Food Chem. 50:3999-4002. Wild, D., Toth, G., and Humpf, H.U. 2003. New Monascus metabolite with a pyridine structure in red fermeted rice. J Agric Food Chem. 51:5493-5496. Wink, D.A., Vodovotz, Y., Laval, J., Laval, F., Dewhirst, M.W., and Mitchell. J.B. 1998. The multifaceted roles of nitric oxide in cancer. Carcinogenesis. 19:711-721. Wu, C.L., Lee, C.L., and Pan, T.M. 2009. Red mold dioscorea has greater anti-hypertensive effect than traditional red mold rice in spontaneously hypertensive rats. J Agri Food Chem. 57:5035-5041. Yamashiro, J. I., Shiraishi, S., Fuwa, Y., Horie, Y. 2008. Dimerumic acid protected oxidative stress-induced cytotoxicity in isolated rat hepatocytes. Cell Biol Toxicol. 24:283-289. Yasukawa, K., Takahashi, M., Natori, S., Kawai, K., Yamazaki, M., Takeuchi, M., and Takido, M. 1994. Azaphilones inhibit tumor promotion by 12-O-tetradecanoylphorbol-13-acetate in two-stage carcinogenesis in mice. Oncology. 51:108-112. Yasukawa, K., Takahashi, M., Natori, S., Kawai, K., Yamazaki, M., Takeuchi, M., and Takido, M. 1996. Inhibitory effects of oral administration of Monascus pigment on tumor promotion in two-Stage carcinogenesis in mouse skin. Oncology. 53:247-249. Yongsmith, B., Krairak, S., and Bavavoda, R., 1994. Production of yellow pigments in submerged culture of a mutant of Monascus spp. J Ferment Bioeng. 78:223-228. Yongsmith, B., Kitprechavanich, V., Chitradon, L., Chaisrisook, C., and Budda, N., 2000. Color mutants of Monascus sp. KB9 and their comparative glucoamylases on rice solid culture. J. Mol. Catal. B: Enzymatic 10:263-272. Zhang, D.Y., Wu, J., Ye, F., Xue, L., Jiang, S., and Yi, J. 2003. Inhibition of cancer cell proliferation and prostaglandin E2 synthesis by Scutellaria Baicalensis. Cancer Res. 63: 4037-4043. | |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/48284 | - |
| dc.description.abstract | 本實驗室利用傳統變異法篩選得到紅麴菌株Monascus purpureus NTU 568,經由動物實驗證實本菌株的發酵產物除了有降血脂功效之外,對減少體脂肪生成和改善阿茲海默症也有效果,在抗腫瘤的研究也發現M. purpureus NTU 568發酵的紅麴米之酒精萃取物可以延緩老鼠肺癌的成長,對於DMBA致癌劑誘發的老鼠口腔癌也有減輕效果。紅麴的主要色素係由黃、橘和紅色素組成,其屬於azaphilone化學結構,已被證實具有抗發炎和抑制癌症生長之效果。本論文研究為探討M. purpureus NTU 568發酵產物中的癌症化學預防成分,其中包含抗癌和抗發炎的azaphilone衍生物以及抗氧化的成分。
利用各種管柱層析及高效液相層析的分離方法,分別從紅麴米甲醇萃取物中分離到14個azaphilone化合物 (1-14) 、紅麴山藥丙酮萃取物中分離到8個azaphione化合物 (1、2、15-20)、紅麴米50%酒精萃取物分離到2個化合物 (33、34)。此外,以兩個黃色素ankaflavin (1) 和monascin (2) 經化學反應,製備6個azaphilone衍生物 (21-26),從兩個橘色素monascorubrin (15) 和 rubropunctatin (16) 則製備4個azaphione衍生物 (27-30) 以及兩個已知的紅色素monascorubramine (31) 和rubropunctamine (32)。上述化合物1-34的結構判斷係經由NMR、MASS、IR、UV等光譜資料的解析;其中11個化合物被確定為首次分離的新化合物,分別為monaphilone A-C (3-5)、monapurpyridine A-B (9-10)、monapurfluore A-B (13-14)、monaphilol A-D (17-20),而化合物21-30則係經由半合成反應所得的新衍生物。 將所獲致的azaphilone類化合物 (1-32) 分析其對人類喉癌 (HEp-2)、人類大腸癌 (WiDr) 和人類乳癌 (MCF-7) 等癌細胞株的抑制生長情形,大多數的化合物具中等程度的抑制效果 (IC50值在20-80 μM之間),化合物 monaphilol A-D (17-20) 的抑制效果最好 (IC50值可達8.6-15.6 μM);且部分化合物對癌細胞具有選擇性抑制作用, 其中monascin (2) 只對HEp-2有抑制作用,FK-17-P2b1 (6)、monasflure A (13) 和monasflure B (12) 則針對MCF-7具抑制作用。進一步探討橘色素 (15-16) 及其衍生物 (17-20、27-32) 的化學結構與生物活性的相關性,發現橘色素8號位置的酮基還原成氫氧基時 (17-20),對HEp-2和WiDr細胞的抑制活性可以提升4-7倍,但如果同時還原14號位置的酮基時 (27-30),原本的抑制效果則會降低,顯示有無8和14號位置的酮基會影響橘色素的對癌細胞生長的抑制活性。 以LPS誘發巨噬細胞 (RAW 264.7) 發炎成生NO的模式分析azaphilone衍生物的抗發炎效果,發現化合物 1-14中只有monasphilone C (5) 和FK-17-P2b1 (6) 沒有抑制發炎效果,其他化合物的抗發炎效果IC50值均在20-30 μM之間,其中只有monapurpyridine B (10) 對RAW 264.7細胞有毒性。化合物 monaphilol A-D (17-20) 在5 μg/mL可以抑制100% 的NO生成,IC50值在1.0-1.7 μM之間,抑制發炎效果較正控制組檞黃素 (quercetin, IC50 = 13.2 μM) 佳。以抑制DPPH自由基生成能力做為抗氧化活性評估指標,由紅麴米50% 酒精萃取物,共分離得到2個抗氧化化合物dimerumic acid (33) 和 deferricoprogen (34),其抑制DPPH自由基生成活性之IC50值分別為16和15 μg/mL,而deferricoprogen (34) 為首次由紅麴中分離到的抗氧化成分。進一步利用HPLC分析紅麴米50% 酒精萃取物的主要成分含量,發現dimerumic acid (33) 和 deferricoprogen (34) 是紅麴米50%酒精萃取物的主要成分,其含量分別為0.85 mg/g和3.00 mg/g。 本實驗從紅麴M. purpureus NTU 568的發酵產物中分離得到21個具抗癌和抗發炎的azaphilone衍生物以及2個主要的抗氧化成分,這些成分的發現和生物活性的證實,有助於紅麴應用於癌症預防的研究,未來將利用這些活性成分探討紅麴防癌的作用機轉,並發展紅麴成為防癌的機能性食品。 | zh_TW |
| dc.description.abstract | In our previous reports, the red mold rice (RMR) fermented by Monascus purpureus NTU 568, mutated by UV irradiation, have been proved for hypolipidemic effects, the regulation of obesity-related factors, and the amelioration of the impairment of memory ability in vivo. Moreover, the ethanol extracts of M. purpureus NTU 568 fermented rice also could mitigate oral carcinogenesis in 7,12-dimethyl-1,2-bena[a]anthracene (DMBA)-induced oral tumor as well as reduce tumor progression of Lewis lung cancer.
Monascus pigments compose of yellow, orange and red pigments which belonged to an azaphilone skeleton, and have been reported to possess anti-inflammantory and anticancer activities. Consequently, the aims of the thesis are to study the bioactive chemical constituents from M. purpureus NTU 568 fermented products and further evaluate their anti-proliferative, anti-inflammatory and anti-oxidative activities of isolates. By column chromatography and high performance liquid chromatography, fourteen (1~14), eight (1, 2, 15~20) azaphilone derivatives and two siderophore skeleton compounds (33 and 34), were isolated from methanol extracts, acetone extracts, and the 50% ethanol extracts of red mold dioscorea (RMD), respectively. Moreover, six azaphilone derivatives (21-26) were derived from yellow pigments, ankaflavin (1) and monascin (2), via chemical reaction. Four azaphione derivatives (27-30) and two known red pigments, monascorubramine (31) and rubropunctamine (32), were also acquired by a short semi-synthesis of orange pigments, monascorubrin (15) and rubropunctatin (16). Structural elucidation of isolated compounds was based on mass, infrared (IR), ultraviolet (UV), and nuclear magnetic resonance (1H-NMR, 13C-NMR, COSY, HMQC, and HMBC) spectroscropic analyses. Of the above mentioned twenty-two isolates, including monaphilone A (3), monaphilone B (4), monaphilone C (5), monapurpyridine A~B (9~10), monapurfluore A (13), monapurfluore B (14), monaphilol A (17), monaphilol B (18), monaphilol C (19), and monaphilol D (20) were verified as new compounds. Compounds 1-32 were further evaluated for their inhibitory effects on the proliferation against human tumor cell lines, HEp-2 (human laryngeal carcinoma) and WiDr (human colon adenocarcinoma), as well as MCF-7 (human breast adenocarcinoma). Bioactive data showed that most of isolates (1-32) had moderate anti-proliferative activities (IC50 : 20 to 80 μM) and monaphilol A-D (17-20) had potent anti-proliferative effect (IC50 : 8 to 15 μM). Monascin (2) exhibited a selective inhibitory effect toward HEp-2, while FK-17-P2b1 (6), monasflure A (13) and monasflure B (12) showed significant inhibitory effects agaist MCF-7. For the structure-activity relationship (SAR) studies of orange pigments (15, 16) and their derivatives (17-20 & 27-32), the anti-proliferative activities of compounds 17-20 with hydroxyl group at C-8 show 4- to 7- fold higher than that of compounds 15 and 16 with ketone group at C-8. However, the anti-proliferative activities of compounds 27-30 were less than compounds 17-20, duo to the hydroxyl groups substituted by ketone groups at C-8 and C-14. Moreover, compounds 1-14, except for monascin (2), monasphilone C (5) and FK-17-P2b1 (6), exhibited promising anti-NO production on LPS-stimulated RAW264.7 macrophages compared with the positive control, quercetin (IC50 : 13.2 μM). Monapurpyridine C (10) showed cytotoxic phenomenon for RAW264.7 cells at 10-15 μg/mL. However, monaphilol A-D (17-20) could reduce LPS-stimulated NO production completely at 5 μg/mL; whereas, they exhibited cytotoxic effects for RAW264.7 cells at 10 μg/mL. Dimerumic acid (DMA) and deferricoprogen (DFC), were isolated from the 50% ethanol extracts of M. purpureus NTU 568 fermented red mold rice (RMR) by antioxidant guided fractionation method. DMA and DFC showed potent DPPH free radical scavenging activities with IC50 value of 16 and 15 μg/mL, respectively. The concentrations of DMA and DFC in RMR were determined as 0.85 and 3.00 mg/g employing HPLC analysis. In this study, twenty-one azaphilone derivatives possessing anti-inflammatory and anti-proliferative effects, as well as two major natural anti-oxidative compounds were isolated and characterize from M. purpureus NTU 568 fermented products. The investigation of chemopreventive mechanism of these bioactive isolates remain to be established. We hope that the potential azaphilone analogues isolated from Monascus purpureus NTU 568 fermented products will be developed as a functional food of cancer chemoprevention. | en |
| dc.description.provenance | Made available in DSpace on 2021-06-15T06:51:15Z (GMT). No. of bitstreams: 1 ntu-100-D93b47103-1.pdf: 12383953 bytes, checksum: e04eac3179658d3874b6a5e5f7278ecb (MD5) Previous issue date: 2011 | en |
| dc.description.tableofcontents | 誌謝……………………………………………………………I
縮寫表 ………………………………………………………………… II 中文摘要………………………………………………………………IV 英文摘要……………………………………………………………VI 化合物1-34之結構式…………………………………………………IX 目錄………………………………………………………………XII 表目錄………………………………………………………………XIV 圖目錄………………………………………………………………XV 第一章 前言……………………………………………………………1 第一節 紅麴菌之介紹 ………………………………………………1 第二節 紅麴在食品上的應用………………………………………3 第三節 紅麴的功效研究………………………………………………4 第四節 紅麴二次代謝物………………………………………………8 第五節 紅麴與癌症防治……………………………………………19 第六節 研究目的與實驗架構………………………………………23 第二章 材料與方法……………………………………………………26 第一節 儀器……………………………………………………26 第二節 藥品……………………………………………………28 第三節 研究方法…………………………………………………29 3-1 Monascus purpureus NTU 568發酵產活性成分分離 及結構解析方法……………………………………………29 3-2 生物活性分析方法……………………………………………30 3-3 HPLC分析方法………………………………………………32 第三章 結構解析 …………………………………………………36 Ankaflavin (1) 和monascin (2) 之結構解析…………………………36 Monaphilone A (3) 和monaphilone B (4) 之結構解析………………45 Monaphilone C (5) 之結構解析……………………………………58 FK17-P2b1 (6) 之結構解析………………………………………67 Monascopyridin D (7) 和C (8) 之結構解析………………72 Monapurpyridin A (10) 和B (11) 之結構解析……………………81 Monasfluore B (11) 和A (12) 之結構解析……………………91 Monapurfluore A (13) 和monapurfluore B (14) 之結構解析…………98 Monascorubrin (15) 和rubropunctatin (16) 之結構解析……………113 Monaphilol A (17)、B (18)、C (19)、D (20) 之結構解析………………121 衍生化之monaphilone D (21)、E (22)、F (23)、G (24) 結構確認……149 衍生化之monaphilone H (25)、I (26) 結構確認……………………163 衍生化之monaphilol E (27)、F (28)、G (29)、H (30) 結構確認……163 Dimerumic acid (33) 和deferricoprogen (34) 之結構解析…………184 第四章 結果與討綸…………………………………………………193 第一節 化合物分離及結構解析結果討論 …………………………194 1. 化合物分離結果討論…………………………………………194 2. 結構解析結果討論……………………………………………195 第二節 抗發炎之活性測試結果及結構與活性相關討論……………197 1. 黃色素及其衍生物抗發炎活性的分析結果 …………………197 2. 吡啶和藍螢光化合物抗發炎活性的分析結果…………………197 3. 橘色素及其衍生物抗發炎活性的分析結果……………………197 4. 化學結構與活性之相關性……………………………………198 第三節 抑制癌細胞增生分析結果及結構與活性相關討論…………204 1. 黃色素及其衍生物的分析結果………………………………204 2. 含吡啶環和藍螢光化合物的分析結果……………………… 205 3. 橘色素及其衍生物的分析結果………………………………206 4. Azaphilone化學結構與活性之相關性…………………………209 第四節 抗氧化活性分析結果………………………………………209 第五節Dimerumic acid (DMA, 33) 和deferricoprogen (DFC, 34) 的定量分析結果………………………………………………211 第五章 結論………………………………………………………………214 第六章 參考文獻…………………………………………………………216 第七章 附錄………………………………………………………………226 附錄一 博士班就讀期間研究成果……………………………………226 一、 國內研討會壁報展出………………………………………226 二、 國際會議壁報展出 …………………………………………227 三、 學術論文 (SCI) ………………………………………………228 附錄二 學術論文全文…………………………………………………230 | |
| dc.language.iso | zh-TW | |
| dc.subject | 紅麴 | zh_TW |
| dc.subject | 抗氧化 | zh_TW |
| dc.subject | 抗發炎 | zh_TW |
| dc.subject | 抗癌 | zh_TW |
| dc.subject | monaphilol | en |
| dc.subject | Monascus purpureus | en |
| dc.subject | anti-proliferative | en |
| dc.subject | anti-inflammatory | en |
| dc.subject | anti-oxidative | en |
| dc.subject | azaphilone | en |
| dc.subject | monaphilone | en |
| dc.title | 紅麴Monascus purpureus NTU 568發酵產物中防癌及其相關活性成分之研究 | zh_TW |
| dc.title | Studies on Cancer Preventive and its related bioactive constituents of Monascus purpureus NTU 568 Fermented Products | en |
| dc.type | Thesis | |
| dc.date.schoolyear | 99-1 | |
| dc.description.degree | 博士 | |
| dc.contributor.coadvisor | 郭曜豪 | |
| dc.contributor.oralexamcommittee | 蘇遠志,黃健雄,江文章,李慶國,李昆達 | |
| dc.subject.keyword | 紅麴,抗癌,抗發炎,抗氧化, | zh_TW |
| dc.subject.keyword | Monascus purpureus,anti-proliferative,anti-inflammatory,anti-oxidative,azaphilone,monaphilone,monaphilol, | en |
| dc.relation.page | 245 | |
| dc.rights.note | 有償授權 | |
| dc.date.accepted | 2011-02-15 | |
| dc.contributor.author-college | 生命科學院 | zh_TW |
| dc.contributor.author-dept | 生化科技學系 | zh_TW |
| 顯示於系所單位: | 生化科技學系 | |
文件中的檔案:
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| ntu-100-1.pdf 未授權公開取用 | 12.09 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。
